Cubist Systematic Strategies, LLC Monte Rosa Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$2.5 - $5.93 $26,505 - $62,869
10,602 New
10,602 $59,000
Q4 2022

Feb 14, 2023
SELL
$6.71 - $9.72 $52,250 - $75,689
-7,787 Reduced 24.03%
24,619 $187,000
Q3 2022

Nov 14, 2022
BUY
$7.17 - $12.16 $232,351 - $394,056
32,406 New
32,406 $265,000
Q4 2021

Feb 14, 2022
SELL
$16.28 - $27.15 $174,700 - $291,346
-10,731 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$18.59 - $42.21 $199,489 - $452,955
10,731 New
10,731 $239,000

Others Institutions Holding GLUE

# of Institutions
93
Shares Held
44.1M
Call Options Held
141K
Put Options Held
31.2K
View Full List

About Monte Rosa Therapeutics, Inc.

GLUE Quotes by TradingView
  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $315M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email